» Articles » PMID: 36352209

The Role of MicroRNAs in Cancer Biology and Therapy from a Systems Biology Perspective

Overview
Date 2022 Nov 9
PMID 36352209
Authors
Affiliations
Soon will be listed here.
Abstract

Since the discovery of microRNAs (miRNAs) in Caenorhabditis elegans, our understanding of their cellular function has progressed continuously. Today, we have a good understanding of miRNA-mediated gene regulation, miRNA-mediated cross talk between genes including competing endogenous RNAs, and miRNA-mediated signaling transduction both in normal human physiology and in diseases.Besides, these noncoding RNAs have shown their value for clinical applications, especially in an oncological context. They can be used as reliable biomarkers for cancer diagnosis and prognosis and attract increasing attention as potential therapeutic targets. Many achievements made in the miRNA field are based on joint efforts from computational and molecular biologists. Systems biology approaches, which integrate computational and experimental methods, have played a fundamental role in uncovering the cellular functions of miRNAs.In this chapter, we review and discuss the role of miRNAs in oncology from a system biology perspective. We first describe biological facts about miRNA genetics and function. Next, we discuss the role of miRNAs in cancer progression and review the application of miRNAs in cancer diagnostics and therapy. Finally, we elaborate on the role that miRNAs play in cancer gene regulatory networks. Taken together, we emphasize the importance of systems biology approaches in our continued efforts to study miRNA cancer regulation.

Citing Articles

Decoding oral cancer: insights from miRNA expression profiles and their regulatory targets.

Wang X, Zhang S, Wang S, Cao T, Fan H Front Mol Biosci. 2025; 11:1521839.

PMID: 39935706 PMC: 11810738. DOI: 10.3389/fmolb.2024.1521839.


A Practical Guideline for MicroRNA Sequencing Data Analysis in Chronic Lymphocytic Leukemia.

Suomela T, Zhang L, Vera J, Bruns H, Lai X Methods Mol Biol. 2024; 2883:403-426.

PMID: 39702719 DOI: 10.1007/978-1-0716-4290-0_18.


An ultrasensitive electrochemical biosensor with dual-amplification mode and enzyme-deposited silver for detection of miR-205-5p.

Xie X, Chen C, Chen W, Qin Y, Xiang S, Jiang J Mikrochim Acta. 2024; 191(9):545.

PMID: 39158763 DOI: 10.1007/s00604-024-06596-7.


miRNA on the Battlefield of Cancer: Significance in Cancer Stem Cells, WNT Pathway, and Treatment.

Bhagtaney L, Dharmarajan A, Warrier S Cancers (Basel). 2024; 16(5).

PMID: 38473318 PMC: 10931375. DOI: 10.3390/cancers16050957.


Plasma small extracellular vesicles from dogs affected by cutaneous mast cell tumors deliver high levels of miR-21-5p.

Zamboni C, Zamarian V, Stefanello D, Ferrari R, Auletta L, Milanesi S Front Vet Sci. 2023; 9:1083174.

PMID: 36704706 PMC: 9871458. DOI: 10.3389/fvets.2022.1083174.

References
1.
Alla V, Kowtharapu B, Engelmann D, Emmrich S, Schmitz U, Steder M . E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry. Cell Cycle. 2012; 11(16):3067-78. PMC: 3442917. DOI: 10.4161/cc.21476. View

2.
Alon U . Network motifs: theory and experimental approaches. Nat Rev Genet. 2007; 8(6):450-61. DOI: 10.1038/nrg2102. View

3.
Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

4.
Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

5.
Baumann V, Winkler J . miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem. 2014; 6(17):1967-84. PMC: 4417715. DOI: 10.4155/fmc.14.116. View